Charlène Esmieu

5PUBLICATIONS
13CO-AUTHORS
Metal cluster chemistryChemical and thermal processes in energy and combustionMedical devicesArtificial life and complex adaptive systemsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 28, 2025
Evaluation of a New Methylimidazole-Containing Thiosemicarbazone as a Cu+/Cu2+-Targeting Ligand in the Context of Alzheimer's Disease.

Barbara Marinho Barbosa, Charlène Esmieu, Antal Galvácsi

|Jan 20, 2024
Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.

Clément Rulmont, Jean-Luc Stigliani, Christelle Hureau

|Jan 06, 2023
Ability of Azathiacyclen Ligands To Stop Cu(Aβ)-Induced Production of Reactive Oxygen Species: [3N1S] Is the Right Donor Set.

Kyangwi P Malikidogo, Marielle Drommi, Elena Atrián-Blasco

|Nov 26, 2022
Sequence-Activity Relationship of ATCUN Peptides in the Context of Alzheimer's Disease.

Margot Lefèvre, Kyangwi P Malikidogo, Charlène Esmieu

|Dec 24, 2021
Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.

Marielle Drommi, Clément Rulmont, Charlène Esmieu

Pageof 1